Your browser doesn't support javascript.
loading
Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes.
Li, Leike; Meng, Weixu; Horton, Melanie; DiStefano, Daniel R; Thoryk, Elizabeth A; Pfaff, Jennifer M; Wang, Qihui; Salazar, Georgina T; Barnes, Trevor; Doranz, Benjamin J; Bett, Andrew J; Casimiro, Danilo R; Vora, Kalpit A; An, Zhiqiang; Zhang, Ningyan.
Afiliação
  • Li L; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
  • Meng W; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
  • Horton M; Department of Infectious Diseases and Vaccines Research, Merck Research Laboratories, Merck and Co. Inc., Kenilworth, New Jersey, United States of America.
  • DiStefano DR; Department of Infectious Diseases and Vaccines Research, Merck Research Laboratories, Merck and Co. Inc., Kenilworth, New Jersey, United States of America.
  • Thoryk EA; Department of Infectious Diseases and Vaccines Research, Merck Research Laboratories, Merck and Co. Inc., Kenilworth, New Jersey, United States of America.
  • Pfaff JM; Integral Molecular, Philadelphia, Pennsylvania, United States of America.
  • Wang Q; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
  • Salazar GT; CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Barnes T; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
  • Doranz BJ; Integral Molecular, Philadelphia, Pennsylvania, United States of America.
  • Bett AJ; Integral Molecular, Philadelphia, Pennsylvania, United States of America.
  • Casimiro DR; Department of Infectious Diseases and Vaccines Research, Merck Research Laboratories, Merck and Co. Inc., Kenilworth, New Jersey, United States of America.
  • Vora KA; Department of Infectious Diseases and Vaccines Research, Merck Research Laboratories, Merck and Co. Inc., Kenilworth, New Jersey, United States of America.
  • An Z; Department of Infectious Diseases and Vaccines Research, Merck Research Laboratories, Merck and Co. Inc., Kenilworth, New Jersey, United States of America.
  • Zhang N; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
PLoS Pathog ; 15(6): e1007716, 2019 06.
Article em En | MEDLINE | ID: mdl-31170257
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cadeias Pesadas de Imunoglobulinas / Cadeias Leves de Imunoglobulina / Vacinas contra Dengue / Anticorpos Neutralizantes / Anticorpos Monoclonais / Anticorpos Antivirais / Epitopos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cadeias Pesadas de Imunoglobulinas / Cadeias Leves de Imunoglobulina / Vacinas contra Dengue / Anticorpos Neutralizantes / Anticorpos Monoclonais / Anticorpos Antivirais / Epitopos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article